50% off all subscriptions! ... left. Order NowOrder Now

Enzon Pharmaceuticals Stock Forecast OTCMKTS:ENZN

$0.39 (-2.50%)

Volume: 2k

Closed: Nov 26, 2021

Hollow Logo Score: -1.140

Enzon Pharmaceuticals Stock Forecast

$0.39 (-2.50%)

Volume: 2k

Closed: Nov 26, 2021

Score Hollow Logo -1.140

ENZN Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.41 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -5.28% during the next 3 months and, with a 90% probability hold a price between $0.27 and $0.38 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-11-30 $0.29 $0.35 $0.40
2021-12-01 $0.29 $0.34 $0.40
2021-12-02 $0.28 $0.34 $0.40
2021-12-03 $0.28 $0.34 $0.40
2021-12-06 $0.28 $0.34 $0.40
2021-12-07 $0.28 $0.34 $0.40
2021-12-08 $0.28 $0.34 $0.40
2021-12-09 $0.28 $0.34 $0.40
2021-12-10 $0.28 $0.34 $0.40
2021-12-13 $0.28 $0.34 $0.40
2021-12-14 $0.28 $0.34 $0.40
2021-12-15 $0.28 $0.34 $0.40
2021-12-16 $0.28 $0.34 $0.40
2021-12-17 $0.28 $0.34 $0.40
2021-12-20 $0.28 $0.34 $0.40
2021-12-21 $0.28 $0.34 $0.40
2021-12-22 $0.28 $0.34 $0.40
2021-12-23 $0.28 $0.34 $0.40
2021-12-27 $0.28 $0.34 $0.40
2021-12-28 $0.28 $0.34 $0.40
2021-12-29 $0.28 $0.34 $0.40
2021-12-30 $0.28 $0.34 $0.40
2021-12-31 $0.28 $0.34 $0.40
2022-01-03 $0.28 $0.34 $0.40
2022-01-04 $0.28 $0.34 $0.40
2022-01-05 $0.28 $0.34 $0.40
2022-01-06 $0.28 $0.34 $0.40
2022-01-07 $0.28 $0.34 $0.40
2022-01-10 $0.28 $0.34 $0.39
2022-01-11 $0.28 $0.33 $0.39

About Enzon Pharmaceuticals

Enzon Pharmaceuticals Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn’s disease. The company was founded in 1981 and is based in Cranford, New Jersey.... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT